Unoprostone ( DrugBank: Unoprostone )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
90	網膜色素変性症	3

90. 網膜色素変性症

---

臨床試験数 : 147 /  薬物数 : 176 - (DrugBank : 43) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 110

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000006820	2009/02/01	02/12/2011	Neuroprotective efficacy of topical unoprostone isopropyl or nipradilol in patients with retinitis pigmentosa	Neuroprotective efficacy of topical unoprostone isopropyl or nipradilol in patients with retinitis pigmentosa - Neuroprotective efficacy of topical unoprostone isopropyl or nipradilol in patients with retinitis pigmentosa	retinitis pigmentosa	0.12% topical unoprostone isopropyl twice daily 0.25% topical nipradilol twice daily	Kyushu university hospital	NULL	Complete: follow-up complete	Not applicable	Not applicable	Male and Female	50	Not selected	Japan
2	JPRN-JapicCTI-090748	01/10/2008	20/04/2009	Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosa	Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosa	retinitis pigmentosa	Intervention name : UF-021 (isopropyl unoprostone) Dosage And administration of the intervention : Eye drop	R-Tech Ueno, Ltd	NULL		20	65	BOTH	105	Phase 2	NULL
3	JPRN-JapicCTI-132079			Phase 3 Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Masked Placebo Controlled Study Period and a Continuous Administration Period	Phase 3 Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Masked Placebo Controlled Study Period and a Continuous Administration Period	Retinitis Pigmentosa	Intervention name : UF-021(isopropyl unoprostone) Dosage And administration of the intervention : Eye drop Control intervention name : null	R-Tech Ueno, Ltd	NULL		20	70	BOTH		Phase 3	NULL